Integer Holdings shareholders voted overwhelming approval for KKR's $5.7 billion take-private transaction, removing the final governance hurdle before Hart-Scott-Rodino clearance and expected close in Q2 2025. The deal values Integer at $119.50 per share, a 31% premium to the 30-day VWAP preceding announcement, and marks KKR's largest healthcare services acquisition since the $3.9 billion Envision Healthcare take-private in 2018.
Integer manufactures implantable cardiac devices, neurostimulation components, and portable medical power systems under long-term supply agreements with Medtronic, Abbott, and Boston Scientific. The company reported $1.47 billion in trailing twelve-month revenue as of Q3 2024, with 78% derived from cardiovascular applications and 22% from neuromodulation. KKR's thesis centers on margin expansion through footprint rationalization—Integer operates 14 facilities across five countries—and accelerated R&D investment in next-generation battery enclosures for leadless pacemakers. The vote passed with 94.7% of outstanding shares tendered, signaling minimal creditor or minority resistance.
The approval lands as private equity shifts capital toward medical device infrastructure plays with visible cash flows and limited regulatory exposure. Integer's customer base operates under FDA 510(k) pathways, not the longer PMA cycles that complicate biotech exits. KKR expects to refinance Integer's existing $850 million term loan and add $2.1 billion in new debt at an estimated blended rate of 7.2%, implying a post-close leverage ratio near 5.8x EBITDA. The structure mirrors KKR's 2021 Barrios Technology acquisition, where operational debt was swapped for agency-backed paper within eighteen months. Worth noting: Integer's top three customers represent 64% of revenue, a concentration risk KKR has historically mitigated through contract renegotiation and multi-year extensions during the first twelve months post-close.
Allocators tracking healthcare services consolidation should watch for Integer's Q1 2025 earnings call, expected mid-April, where management will detail transition planning and any customer reassurance protocols. KKR's prior medtech carveouts—Agiliti in 2020, Envision in 2018—both saw 12-18 month operational restructuring windows before margin improvement became visible. Second, monitor Abbott and Medtronic's Q1 guidance for any supply-chain commentary; OEMs occasionally pre-announce alternate sourcing during ownership transitions. Third, track KKR's leverage refinancing strategy: if high-yield spreads tighten below 425 basis points by June, expect an opportunistic repricing that could fund incremental capex for Integer's India and Malaysia facilities.
The HSR clock starts now. Integer's largest manufacturing site sits in Tijuana, handling $420 million in annual output, and any CFIUS review would add 45-60 days to close timing—but KKR has pre-cleared foreign ownership protocols through the Defense Production Act office given Integer's Veterans Affairs contracts. The real tell will be whether KKR brings in a co-investor before close or holds the entire equity check, a signal of conviction rarely seen at this ticket size outside infrastructure.
The takeaway
$5.7B Integer approval sets Q2 close; KKR's leverage refinancing strategy and customer contract renewals will define margin trajectory by year-end.
Editorial & Disclosure Notice: This article was written with artificial intelligence from public sources and is published without individual human review. Artificial intelligence and other digital tools are also used for research, analysis, editing, formatting, and production. Errors, omissions, outdated information, or inaccuracies may occur. References to companies, brands, products, services, organizations, or individuals are for informational and editorial purposes and do not imply endorsement, sponsorship, affiliation, partnership, or approval unless expressly stated. All trademarks and other intellectual property remain the property of their respective owners. Opinions, analysis, estimates, and commentary are informational only and should not be construed as financial, investment, legal, tax, medical, procurement, or other professional advice. Information may be corrected, clarified, or updated after publication. Corrections or removal requests: jenny@pops4.com.
Want the 60-second program for your specific event?
Enter your event and email — we build it and send the branded proposal before lunch. No obligation.
The branded-identity layer Chiefs of Staff and heritage CMOs route through — your name imprinted on real authorized stock, your pick of 200+ brands and 70,000 products, shipped from one accountable house. Nine editorial desks publish the intelligence those operators read before they sign.
200+authorized brands
70,000products · virtual proof on each
9 deskspublishing daily
1997one house, since
70,000 SKUs · virtual proof in 60 seconds · no platform fee · blind-shipped · ASI #217876
Your next customer won't visit your website. Their AI will.
AI assistants have quietly taken over the first step of buying — they answer from catalogs they can read and shortlist whoever can actually ship. Two questions now decide whether you exist to that buyer: can a machine read your catalog, and can you fulfill the order. Most brands fail one or both and never find out why the orders went elsewhere. The winners of this shift aren't the loudest. They're the most readable. Build for the machine that's about to do the shopping.
Built by the craft floor — apparel, media, packaging, and secure print.
This trade runs on hands, not desks. Imprint manufacturing & Komori heritage press through approved vendors · Canon high-speed secure-media operations is a craft floor — genuine Six Sigma discipline applied to ink, thread, foil, and registration, where a hundredth of an inch is the difference between a brand that reads serious and one that reads cheap. POPS4 is built by exactly those operators: independent, boots-on-the-ground engineers who carry their own book, read a client in microseconds, and put their name on every run. Beyond our own Virginia Beach floor, we work with a vetted network of craft manufacturers across the US — each meeting the highest excellence in QC standards in the industry, each a specialist in its own discipline — so apparel, hard-goods imprinting, media manufacturing, packaging, and secure printing all go to the bench built for them, coordinated from one accountable hub. Short-run from twenty-five units, volume to five hundred thousand. Two hundred authorized national brands, seventy thousand SKUs with virtual proofing on every one. Art archived for instant reorders. Net-thirty corporate terms, NDA-standard white-label — your name on the work, or none at all.
Strategy, positioning, identity, creative, and messaging — wired into an AI system that publishes and distributes on its own. Nine editorial desks generate the authority, the production house ships the physical proof, and the attribution layer tells you which post sold which SKU. What you get is an operating layer — content, catalog, and order path under one roof — that keeps working whether or not you are in the room. Built for principals who would rather own the machine than rent the agency.
Named-account programs — one desk, quiet delivery, NDA-standard.
One point of contact who already knows the file, so nothing restarts from zero between engagements. The work ships blind, under NDA, with your name on it or none at all. Built for single-family offices, heritage-house CMOs, sports-ownership groups, and the agencies that white-label our production. The relationship is the product; the merch is the proof of it.
SFO · Chief of Staff desk. Principal household, properties, aircraft, yacht, calendar, philanthropy — one file.
Shop seventy thousand products. Virtual proof on every one. 24/7.
Drop your logo on any product and see the virtual proof before asking. Quote routes direct to the desk. MCP catalog for AI agents. Celeste for the fast conversation. Full self-service checkout in development.